Microenvironmental regulation of inducible nitric oxide synthase expression and nitric oxide production in mouse bone marrow-derived mast cells

Journal of Leukocyte Biology

Volumn 91, Issue 4, 2012, Pages 581-590

  Moon, Tae Chul ^a   Yoshimura, Tsuyoshi ^a   Parsons, Thomas ^a   Dean Befus, A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Interleukin 3; Interleukin 4; Mast cell protease; Phenotype; Stem cell factor (SCF)

Indexed keywords

CHYMASE; GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 3; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; STEM CELL FACTOR RECEPTOR;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL CULTURE; CELL MATURATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MAST CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

ANIMALS; BONE MARROW CELLS; CYTOKINES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MAST CELLS; MICE; MICE, INBRED BALB C; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELL NICHE; STEM CELLS; TIME FACTORS;

EID: 84860865736     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0811436     Document Type: Article

References (80)

1. Moon, T. C., St Laurent, C. D., Morris, K. E., Marcet, C., Yoshimura, T., Sekar, Y., Befus, A. D. (2010) Advances in mast cell biology: new understanding of heterogeneity and function. Mucosal. Immunol. 3, 111-128.
2. Marshall, J. S. (2004) Mast-cell responses to pathogens. Nat. Rev. Immunol. 4, 787-799.
3. Galli, S. J., Nakae, S., Tsai, M. (2005) Mast cells in the development of adaptive immune responses. Nat. Immunol. 6, 135-142.
4. Galli, S. J., Kalesnikoff, J., Grimbaldeston, M. A., Piliponsky, A. M., Williams, C. M., Tsai, M. (2005) Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol. 23, 749-786.
5. Bruckdorfer, R. (2005) The basics about nitric oxide. Mol. Aspects Med. 26, 3-31.
6. Bove, P. F., van der Vliet, A. (2006) Nitric oxide and reactive nitrogen species in airway epithelial signaling and inflammation. Free Radic. Biol. Med. 41, 515-527.
7. Pacher, P., Beckman, J. S., Liaudet, L. (2007) Nitric oxide and peroxyni-trite in health and disease. Physiol. Rev. 87, 315-424.
8. Wink, D. A., Hines, H. B., Cheng, R. Y., Switzer, C. H., Flores-Santana, W., Vitek, M. P., Ridnour, L. A., Colton, C. A. (2011) Nitric oxide and redox mechanisms in the immune response. J. Leukoc. Biol. 89, 873-891.
9. Hamid, Q., Springall, D. R., Riveros-Moreno, V., Chanez, P., Howarth, P., Redington, A., Bousquet, J., Godard, P., Holgate, S., Polak, J. M. (1993) Induction of nitric oxide synthase in asthma. Lancet 342, 1510-1513.
10. Kitajima, I., Kawahara, K, Nakajima, T., Soejima, Y., Matsuyama, T., Maruyama, I. (1994) Nitric oxide-mediated apoptosis in murine mastocytoma. Biochem. Biophys. Res. Commun. 204, 244-251.
11. Huang, J., Roby, K. F., Pace, J. L., Russell, S. W., Hunt, J. S. (1995) Cellular localization and hormonal regulation of inducible nitric oxide synthase in cycling mouse uterus. J. Leukoc. Biol. 57, 27-35.
12. Wills, F. L., Gilchrist, M., Befus, A. D. (1999) Interferon-γ regulates the interaction of RBL-2H3 cells with fibronectin through production of nitric oxide. Immunology 97, 481-489.
13. Gajkowska, B., Gniadecki, R (1999) Induction of endothelial nitric oxide synthase in perivascular mast cells in rat neurohypophysis after ischemia. Neuroendocrinol. Lett. 20, 189-193.
14. Gilchrist, M., Savoie, M., Nohara, O., Wills, F. L., Wallace, J. L., Befus, A. D. (2002) Nitric oxide synthase and nitric oxide production in in vivo-derived mast cells. J. Leukoc. Biol. 71, 618-624.
15. Bidri, M., Ktorza, S., Vouldoukis, I., Le Goff, L., Debre, P., Guillosson, J. J., Arock, M. (1997) Nitric oxide pathway is induced by Fc ε RI and up-regulated by stem cell factor in mouse mast cells. Eur. J. Immunol. 27, 2907-2913.
16. Gilchrist, M., McCauley, S. D., Befus, A. D. (2004) Expression, localization, and regulation of NOS in human mast cell lines: effects on leukotri-ene production. Blood 104, 462-469.
17. Kim, S. J., Jeong, H. J., Choi, I. Y., Lee, K. M., Park, R K, Hong, S. H., Kim, H. M. (2005) Cyclooxygenase-2 inhibitor SC-236 [4-[5-(4-chlorophe-nyl)-3-(trifluoromethyl)-1-pyrazol-1-l] benzenesulfonamide] suppresses nuclear factor-KB activation and phosphorylation of p38 mitogen-acti-vated protein kinase, extracellular signal-regulated kinase, and c-Jun N-terminal kinase in human mast cell line cells. J. Pharmacol. Exp. Ther. 314, 27-34.
18. Salvemini, D., Masini, E., Anggard, E., Mannaioni, P. F., Vane, J. (1990) Synthesis of a nitric oxide-like factor from L-arginine by rat serosal mast cells: stimulation of guanylate cyclase and inhibition of platelet aggregation. Biochem. Biophys. Res. Commun. 169, 596-601.
19. Mannaioni, P. F., Masini, E., Pistelli, A, Salvemini, D., Vane, J. R (1991) Rat mast cells inhibit platelet aggregation by releasing a nitric oxide-like factor: influence of histamine release. Agents Actions Suppl. 33, 423-428.
20. Eastmond, N. C, Banks, E. M., Coleman, J. W. (1997) Nitric oxide inhibits IgE-mediated degranulation of mast cells and is the principal intermediate in IFN-γ-induced suppression of exocytosis. J. Immunol. 159, 1444-1450.
21. Coleman, J. W. (2002) Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin. Exp. Immunol. 129, 4-10.
22. Davis, B. J., Flanagan, B. F., Gilfillan, A. M., Metcalfe, D. D., Coleman, J. W. (2004) Nitric oxide inhibits IgE-dependent cytokine production and Fos andJun activation in mast cells. J. Immunol. 173, 6914-6920.
23. Forsythe, P., Befus, A. D. (2003) Inhibition of calpain is a component of nitric oxide-induced down-regulation of human mast cell adhesion. J. Immunol. 170, 287-293.
24. Nohara, O., Kulka, M., Dery, R E., Wills, F. L., Hirji, N. S., Gilchrist, M., Befus, A. D. (2001) Regulation of CD8 expression in mast cells by exogenous or endogenous nitric oxide. J. Immunol. 167, 5935-5939.
25. Bissonnette, E. Y, Hogaboam, C. M., Wallace, J. L., Befus, A. D. (1991) Potentiation of tumor necrosis factor-a-mediated cytotoxicity of mast cells by their production of nitric oxide. J. Immunol. 147, 3060-3065.
26. Moon, T. C, Befus, A. D. (2008) Exogenous nitric oxide regulates cyclooxygenase-2 expression and prostaglandin D(2) generation through p38 MAPK in mouse bone marrow-derived mast cells. Free Radic. Biol. Med 45, 780-788.
27. Moon, T.C., Sekar, Y, Befus, AD. (2009) Effects of nitric oxide on mast cells: production, functions, and mechanisms of action. In Allergy Fronters: Classification and Pathomechanisms, vol. 2 (R Pawankar, S. T. Holgate, L. J. Rosenwasser, eds.), Springer, Tokyo, Japan, 315-327.
28. Yip, K. H., Huang, Y, Waye, M. M., Lau, H. Y (2008) Induction of nitric oxide synthases in primary human cultured mast cells by IgE and proinflammatory cytokines. Int. Immunopharmacol. 8, 764-768.
29. Swindle, E. J., Metcalfe, D. D., Coleman, J. W. (2004) Rodent and human mast cells produce functionally significant intracellular reactive oxygen species but not nitric oxide. J. Biol. Chem. 279, 48751-48759.
30. Gilchrist, M., Hesslinger, C, Befus, A. D. (2003) Tetrahydrobiopterin, a critical factor in the production and role of nitric oxide in mast cells. J. Biol. Chem. 278, 50607-50614.
31. Bacci, S., Arbi-Riccardi, R, Mayer, B., Rumio, C, Borghi-Cirri, M. B. (1994) Localization of nitric oxide synthase immunoreactivity in mast cells of human nasal mucosa. Histochemistry 102, 89-92.
32. Shimizu, Y, Sakai, M., Umemura, Y, Ueda, H. (1997) Immunohisto-chemical localization of nitric oxide synthase in normal human skin: expression of endothelial-type and inducible-type nitric oxide synthase in keratinocytes. J. Dermatol. 24, 80-87.
33. Bacci, S., Rucci, L., Riccardi-Arbi, R, Borghi-Cirri, M. B. (1998) Colocal-ization of tumor necrosis factor-a and nitric oxide-synthase immunoreactivity in mast cell granules of nasal mucosa. Histol. Histopathol. 13, 1011-1014.
34. Gajkowska, B., Viron, A, Cholewinski, M. (1999) Immunocytochemical localization of endothelial nitric oxide synthase (e-NOS) and inducible nitric oxide synthase (i-NOS) in rat neurohypophysis after transient cerebral ischemia. Folia Neuropathol. 37, 10-19.
35. Messina, A., Knight, K. R., Dowsing, B. J., Zhang, B., Phan, L. H., Hurley, J. V., Morrison, W. A., Stewart, A. G. (2000) Localization of inducible nitric oxide synthase to mast cells during ischemia/reperfusion injury of skeletal muscle. Lab. Invest. 80, 423-431.
36. Koda, W., Harada, K, Tsuneyama, K, Kono, N., Sasaki, M., Matsui, O., Nakanuma, Y. (2000) Evidence of the participation of peribiliary mast cells in regulation of the peribiliary vascular plexus along the intrahepatic biliary tree. Lab. Invest. 80, 1007-1017.
37. Bacci, S., Pieri, L., Buccoliero, A. M., Bonelli, A, Taddei, G., Romagnoli, P. (2008) Smooth muscle cells, dendritic cells and mast cells are sources of TNFa and nitric oxide in human carotid artery atherosclerosis. Thromb. Res. 122, 657-667.
38. Bacci, S., Faussone-Pellegrini, S., Mayer, B., Romagnoli, P. (1995) Distribution of mast cells in human ileocecal region. Dig. Dis. Sci. 40, 357-365.
39. Kitamura, Y. (1989) Heterogeneity of mast cells and phenotypic change between subpopulations. Annu. Rev. Immunol. 7, 59-76.
40. Rottem, M., Goff, J. P., Albert, J. P., Metcalfe, D. D. (1993) The effects of stem cell factor on the ultrastructure of Fc e RI+ cells developing in IL-3-dependent murine bone marrow-derived cell cultures. J. Immunol. 151, 4950-4963.
41. Karimi, K, Redegeld, F. A, Heijdra, B., Nijkamp, F. P. (1999) Stem cell factor and interleukin-4 induce murine bone marrow cells to develop into mast cells with connective tissue type characteristics in vitro. Exp. Hematol. 27, 654-662.
42. Levi-Schaffer, F., Austen, K. F., Gravallese, P. M., Stevens, R L. (1986) Coculture of interleukin 3-dependent mouse mast cells with fibroblasts results in a phenotypic change of the mast cells. Proc. Natl. Acad. Sci. USA 83, 6485-6488.
43. Dayton, E. T., Pharr, P., Ogawa, M., Serafin, W. E., Austen, K. F., Levi-Schaffer, F., Stevens, R L. (1988) 3T3 fibroblasts induce cloned interleukin 3-dependent mouse mast cells to resemble connective tissue mast cells in granular constituency. Proc. Natl. Acad. Sci. USA 85, 569-572.
44. Tsai, M., Takeishi, T., Thompson, H., Langley, K. E., Zsebo, K. M., Metcalfe, D. D., Geissler, E. N., Galli, S.J. (1991) Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc. Natl. Acad. Sci. USA 88, 6382-6386.
45. Moon, T. C, Murakami, M., Ashraf, M. D., Kudo, I., Chang, H. W. (1998) Regulation of cyclooxygenase-2 and endogenous cytokine expression by bacterial lipopolysaccharide that acts in synergy with c-kit ligand and Fc e receptor I crosslinking in cultured mast cells. Cell. Immunol. 185, 146-152.
46. Lee, E., Yook, J., Haa, K, Chang, H. W. (2005) Induction ofYm1/2 in mouse bone marrow-derived mast cells by IL-4 and identification of Ym1/2 in connective tissue type-like mast cells derived from bone marrow cells cultured with IL-4 and stem cell factor. Immunol. Cell Biol. 83, 468-474.
47. Enerback, L. (1974) Berberine sulphate binding to mast cell polyanions: a cytofluorometric method for the quantitation of heparin. Histochemistry 42, 301-313.
48. Miljkovic, D., Trajkovic, V. (2004) Inducible nitric oxide synthase activation by interleukin-17. Cytokine Growth Factor Rev. 15, 21-32.
49. Kleinert, H., Pautz, A, Linker, K, Schwarz, P. M. (2004) Regulation of the expression of inducible nitric oxide synthase. Eur. J. Pharmacol. 500, 255-266.
50. Alderton, W. K, Cooper, C. E., Knowles, R G. (2001) Nitric oxide synthases: structure, function and inhibition. Biochem. J. 357, 593-615.
51. Proskuryakov, S. Y, Konoplyannikov, A. G., Skvortsov, V. G., Mandrugin, A. A, Fedoseev, V. M. (2005) Structure and activity of NO synthase inhib itors specific to the L-arginine binding site. Biochemistry (Mosc). 70, 8-23.
52. Garvey, E. P., Oplinger, J. A, Furfine, E. S., Kiff, R J., Laszlo, F., Whittle, B. J., Knowles, R G. (1997) 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 272, 4959-4963.
53. Gilchrist, M., Befus, A.D. (2008) Interferon-7 regulates chemokine expression and release in the human mast cell line HMC1: role of nitric oxide. Immunology 123, 209-217.
54. Nakano, T., Sonoda, T., Hayashi, C, Yamatodani, A, Kanayama, Y, Yamamura, T., Asai, H., Yonezawa, T., Kitamura, Y, Galli, S.J. (1985) Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J. Exp. Med. 162, 1025-1043.
55. Wolters, P. J., Mallen-St Clair, J., Lewis, C. C, Villalta, S. A, Baluk, P., Erle, D. J., Caughey, G. H. (2005) Tissue-selective mast cell reconstitution and differential lung gene expression in mast cell-deficient Kit(W-sh)/ Kit(W-sh) sash mice. Clin. Exp. Allergy 35, 82-88.
56. Kitamura, Y, Go, S., Hatanaka, K. (1978) Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 52, 447-452.
57. Duttlinger, R, Manova, K, Chu, T. Y, Gyssler, C, Zelenetz, A. D., Bach-varova, R F., Besmer, P. (1993) W-sash affects positive and negative elements controlling c-kit expression: ectopic c-kit expression at sites of kit-ligand expression affects melanogenesis. Development 118, 705-717.
58. Kitamura, Y, Go, S. (1979) Decreased production of mast cells in S1/S1d anemic mice. Blood 53, 492-497.
59. Stolz, D. B., Zamora, R., Vodovotz, Y, Loughran, P. A, Billiar, T. R, Kim, Y M., Simmons, R L., Watkins, S. C. (2002) Peroxisomal localization of inducible nitric oxide synthase in hepatocytes. Hepatology 36, 81-93.
60. Loughran, P. A, Stolz, D. B., Vodovotz, Y, Watkins, S. C, Simmons, R L., Billiar, T. R (2005) Monomeric inducible nitric oxide synthase localizes to peroxisomes in hepatocytes. Proc. Natl. Acad. Sci USA 102, 13837-13842.
61. Webb, J. L., Polak, J. M., Evans, T.J. (2001) Effect of adhesion on inducible nitric oxide synthase (iNOS) production in purified human neutrophils. Clin. Exp. Immunol. 123, 42-48.
62. Webb, J. L., Harvey, M. W., Holden, D. W., Evans, T.J. (2001) Macrophage nitric oxide synthase associates with cortical actin but is not recruited to phagosomes. Infect. Immun. 69, 6391-6400.
63. Burkholder, KM., Perry, J.W., Wobus, C.E., Donato, N.J., Showalter, H.D., Kapuria, V., O'Riordan, M.X. (2011) A small molecule deubiquitinase inhibitor increases localization of inos to the macrophage phagosome and enhances bacterial killing. Infect. Immun. 79, 4850-4857.
64. Sekar, Y, Moon, T. C, Munoz, S., Befus, A. D. (2005) Role of nitric oxide in mast cells: controversies, current knowledge, and future applications. Immunol. Res. 33, 223-239.
65. Yip, K, Leung, F., Huang, Y, Lau, H. (2009) Inhibition of anti-IgE mediated human mast cell activation by NO donors is dependent on their NO release kinetics. Br. J. Pharmacol. 156, 1279-1286.
66. Zaman, K, Hanigan, M. H., Smith, A, Vaughan, J., Macdonald, T., Jones, D. R, Hunt, J. F., Gaston, B. (2006) Endogenous S-nitrosoglutathione modifies 5-lipoxygenase expression in airway epithelial cells. Am. J. Respir. Cell Mol. Biol. 34, 387-393.
67. Sakai, N., Kaufman, S., Milstein, S. (1993) Tetrahydrobiopterin is required for cytokine-induced nitric oxide production in a murine macrophage cell line (RAW 264). Mol. Pharmacol. 43, 6-10.
68. Forsythe, P., Gilchrist, M., Kulka, M., Befus, A. D. (2001) Mast cells and nitric oxide: control of production, mechanisms of response. Int. Immuno-pharmacol. 1, 1525-1541.
69. McCauley, S. D., Gilchrist, M., Befus, A. D. (2007) Regulation and function of the protein inhibitor of nitric oxide synthase (PIN)/dynein light chain 8 (LC8) in a human mast cell line. Life Sci. 80, 959-964.
70. Stone, W. L., Yang, H., Qui, M. (2006) Assays for nitric oxide expression. Methods Mol. Biol. 315, 245-256.
71. Yamashita, M., Nakayama, T. (2008) Progress in allergy signal research on mast cells: regulation of allergic airway inflammation through Tolllike receptor 4-mediated modification of mast cell function. J. Pharmacol. Sci. 106, 332-335.
72. Brzezinska-Blaszczyk, E., Rdzany, R S. (2006) Lipopolysaccharides and lipoteichoic acids stimulate rat mast cells to cysteinyl leukotriene synthesis. Med. Dosw. Mikrobiol. 58, 223-229.
73. Seo, J. Y, Kim, D. Y, Lee, Y S., Ro, J. Y (2009) Cytokine production through PKC/p38 signaling pathways, not through JAK/STAT1 pathway, in mast cells stimulated with IFN7. Cytokine46, 51-60.
74. Yoshimura, T, Moon, T C., St Laurent, C. D., Puttagunta, L., Chung, K, Wright, E., Yoshikawa, M., Moriyama, H., Befus, A D. (2012) Expression of ni tric oxide synthases in leukocytes in nasal polyps. Ann. Allergy Asthma Immunol. In press.
75. Gilroy, D. W., Colville-Nash, P. R, Willis, D., Chivers, J., Paul-Clark, M. J., Willoughby, D. A. (1999) Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 5, 698-701.
76. Rajakariar, R, Hilliard, M., Lawrence, T., Trivedi, S., Colville-Nash, P., Bellingan, G., Fitzgerald, D., Yaqoob, M. M., Gilroy, D. W. (2007) Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyA12 14 PGJ2. Proc. Natl. Acad. Sci. USA 104, 20979-20984.
77. Dugas, B., Paul-Eugene, N., Yamaoka, K, Amirand, C, Damais, C, Kolb, J. P. (1995) IL-4 induces cAMP and cGMP in human monocytic cells. Mediators Inflamm. 4, 298-305.
78. Levesque, M.C., Misukonis, M.A, O'Loughlin, C.W., Chen, Y, Beasley, B.E., Wilson, D.L., Adams, D.J., Silber, R, Weinberg, J.B. (2003) IL-4 and interferon 7 regulate expression of inducible nitric oxide synthase in chronic lymphocytic leukemia cells. Leukemia 17, 442-450.
79. Levesque, M.C., Chen, Y, Beasley, B.E., O'Loughlin, C.W., Gockerman, J.P., Moore, JO., Weinberg, J.B. (2006) Chronic lymphocytic leukemia cell CD38 expression and inducible nitric oxide synthase expression are associated with serum IL-4 levels. Leuk. Res. 30, 24-28.
80. Doyle, A. G., Herbein, G., Montaner, L. J., Minty, A. J., Caput, D., Ferrara, P., Gordon, S. (1994) Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-γ. Eur. J. Immunol. 24, 1441-1445.